Man Tong Selected Research

Drug Therapy (Chemotherapy)

3/2021	Chemotherapy-Enriched THBS2-Deficient Cancer Stem Cells Drive Hepatocarcinogenesis through Matrix Softness Induced Histone H3 Modifications.
4/2016	C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
7/2014	Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Man Tong Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 11/2012
13	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2014
6	Liver Neoplasms (Liver Cancer) 01/2022 - 12/2016
6	Neoplasm Metastasis (Metastasis) 11/2021 - 04/2013
2	Tics (Tic) 11/2021 - 07/2014
2	Carcinogenesis 11/2017 - 04/2016
2	Residual Neoplasm 04/2016 - 07/2014
1	Fibrosis (Cirrhosis) 11/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Infections 04/2016
1	Lymphatic Metastasis 01/2016
1	Esophageal Squamous Cell Carcinoma 01/2016
1	Nerve Degeneration 05/2014
1	Embryo Loss 07/2012
1	Fetal Death 07/2010

Drug/Important Bio-Agent (IBA)

7	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 10/2018
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2014
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2021 - 04/2013
3	CateninsIBA 01/2021 - 12/2016
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2020
2	Glutamine (L-Glutamine)FDA Link 11/2021 - 01/2021
2	EnzymesIBA 11/2021 - 01/2021
2	Tyrosine (L-Tyrosine)FDA Link 11/2021 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 03/2021 - 04/2013
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 01/2017
2	Annexin A3IBA 10/2018 - 07/2015
2	Monoclonal AntibodiesIBA 10/2018 - 07/2015
2	Neutralizing AntibodiesIBA 11/2017 - 01/2016
2	Small Interfering RNA (siRNA)IBA 11/2017 - 07/2010
1	CholesterolIBA 01/2022
1	AC133 AntigenIBA 01/2022
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	lenvatinibIBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2021
1	Vasodilator Agents (Vasodilators)IBA 12/2021
1	ifenprodilIBA 12/2021
1	Drug CombinationsIBA 12/2021
1	FollistatinIBA 11/2021
1	Conditioned Culture MediaIBA 11/2021
1	CollagenIBA 03/2021
1	Histones (Histone)IBA 03/2021
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	regorafenibIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2017
1	Glycogen Synthase KinasesIBA 12/2016
1	MicroRNAs (MicroRNA)IBA 12/2016
1	hepatitis B virus X proteinIBA 04/2016
1	Neuropilin-2IBA 01/2016
1	cathepsin SIBA 07/2014
1	PAR-2 ReceptorIBA 07/2014
1	IntegrinsIBA 11/2012
1	Prostaglandins DIBA 07/2012

Therapy/Procedure

9	Therapeutics 01/2022 - 07/2014
3	Drug Therapy (Chemotherapy) 03/2021 - 07/2014
1	Transplantation 01/2022
1	Immunotherapy 10/2021
1	Intravenous Administration 01/2021